PT Diagnos Laboratorium Utama Tbk (DGNS.JK)
IDR 169.0
(0.59%)
IDR 169.0
(0.59%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 51 Billion IDR | 247.11% |
| 2022 | 14.69 Billion IDR | 128.08% |
| 2021 | 6.44 Billion IDR | 182.91% |
| 2020 | 2.27 Billion IDR | -34.74% |
| 2019 | 3.48 Billion IDR | -33.21% |
| 2018 | 5.22 Billion IDR | 4530.86% |
| 2017 | 112.8 Million IDR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 61.01 Billion IDR | 6.64% |
| 2024 Q1 | 57.21 Billion IDR | 0.8% |
| 2023 Q1 | 25.74 Billion IDR | 75.2% |
| 2023 Q2 | 24.4 Billion IDR | -5.18% |
| 2023 FY | 56.76 Billion IDR | 286.31% |
| 2023 Q4 | 56.76 Billion IDR | 48.43% |
| 2023 Q3 | 38.24 Billion IDR | 56.67% |
| 2022 FY | 14.69 Billion IDR | 128.08% |
| 2022 Q4 | 14.69 Billion IDR | 54.74% |
| 2022 Q3 | 9.49 Billion IDR | -6.07% |
| 2022 Q2 | 10.11 Billion IDR | 70.71% |
| 2022 Q1 | 5.92 Billion IDR | -8.07% |
| 2021 Q1 | 2.62 Billion IDR | 34.67% |
| 2021 FY | 6.44 Billion IDR | 182.91% |
| 2021 Q3 | 5.59 Billion IDR | 128.57% |
| 2021 Q4 | 6.44 Billion IDR | 15.16% |
| 2021 Q2 | 2.44 Billion IDR | -6.85% |
| 2020 Q1 | - IDR | -100.0% |
| 2020 FY | 2.27 Billion IDR | -34.74% |
| 2020 Q4 | 1.95 Billion IDR | 0.0% |
| 2020 Q2 | 1.62 Billion IDR | 0.0% |
| 2019 Q4 | 2.58 Billion IDR | 0.0% |
| 2019 FY | 3.48 Billion IDR | -33.21% |
| 2019 Q3 | 2.58 Billion IDR | 0.0% |
| 2018 FY | 5.22 Billion IDR | 4530.86% |
| 2017 FY | 112.8 Million IDR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| PT Prodia Widyahusada Tbk | 31.36 Billion IDR | -62.631% |